510(k) K063821
K063821 is an FDA 510(k) premarket notification submitted by Nova Biomedical Corp. for the device "NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM". The FDA issued a decision of Substantially Equivalent on January 24, 2007. The device falls under product code CGA (Glucose Oxidase, Glucose), a Class II device regulated under 21 CFR 862.1345. Nova Biomedical Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 2007
- Date Received
- December 26, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Oxidase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type